The Journal of Organic Chemistry
Page 4 of 6
127.3, 122.5, 53.6, 53.5, 21.5; HRMS (ESI) m/z: [M + H]+ Calcd
for C15H15N2O4 287.1026, Found 287.1025.
129.5, 120.1, 114.1, 112.4, 55.3, 52.4, 52.3; HRMS (ESI) m/z: [M
+ H]+ Calcd for C14H15N2O5 291.0975, Found 291.0973.
1
2
3
4
5
6
7
8
Dimethyl
6-(4-(trifluoromethyl)phenyl)pyridazine-3,4-
Dimethyl 3-(p-tolyl)-1H-pyrazole-4,5-dicarboxylate. Compound
3c (64 mg, Y = 78%, Rf = 0.23 (PE:EA = 2:1)) was isolated as a
yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.0 Hz, 2H),
7.17 (d, J = 7.6 Hz, 2H), 3.81 (s, 3H), 3.74 (s, 3H), 2.35 (s, 3H);
13C NMR (100 MHz, CDCl3) δ 164.3, 161.3, 146.2, 141.4, 139.6,
129.3, 127.8, 125.1, 112.6, 52.3, 52.2, 21.2; HRMS (ESI) m/z: [M
+ H]+ Calcd for C14H15N2O4 275.1026, Found 275.1027.
dicarboxylate. Compound 2d (66 mg, Y = 65%, Rf = 0.52 (PE:EA
= 2:1)) was isolated as a yellow solid; mp 85.2−86.2 °C. 1H NMR
(400 MHz, CDCl3) δ 8.25 (d, J = 8.4 Hz, 2H), 8.24 (s, 1H), 7.78
(d, J = 8.4 Hz, 2H), 4.04 (s, 3H), 3.98 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 164.7, 164.1, 159.3, 150.2, 137.8,132.7 (q, J =
32.6 Hz), 129.7, 127.8, 126.1 (q, J = 3.7 Hz),123.6 (q, J = 270.8
Hz), 123.3, 53.6, 53.5; HRMS (ESI) m/z [M + Na]+ Calcd for
C15H11F3N2O4Na 363.0563, Found 363.0562.
Dimethyl
3-(4-(trifluoromethyl)phenyl)-1H-pyrazole-4,5-
dicarboxylate. Compound 3d (80 mg, Y = 81%, Rf = 0.56 (PE:EA
9
1
Dimethyl
6-(4-fluorophenyl)pyridazine-3,4-dicarboxylate.
= 2:1)) was isolated as a yellow oil. H NMR (400 MHz, CDCl3)
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Compound 2e (51 mg, Y = 59%, Rf = 0.48 (PE:EA = 2:1)) was
isolated as a yellow solid; mp 82.3−82.9 °C. 1H NMR (400 MHz,
CDCl3) δ 8.18–8.12 (m, 3H), 7.26–7.19 (m, 2H), 4.06 (s, 3H),
3.98 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.9, 164.8 (d, J =
251.1 Hz), 164.4, 159.5, 149.4, 130.6 (d, J = 3.1 Hz), 129.9, 129.5
(d, J = 8.8 Hz), 122.5, 116.4 (d, J = 21.8 Hz), 53.6, 53.4; HRMS
(ESI) m/z: [M + H]+ Calcd for C14H12FN2O4 291.0776, Found
291.0774.
Dimethyl 6-(furan-2-yl)pyridazine-3,4-dicarboxylate. Compound
2f (45 mg, Y = 57%, Rf = 0.56 (PE:EA = 1:1)) was isolated as a
red solid; mp 149.3−149.6 °C. 1H NMR (400 MHz, CDCl3) δ 8.08
(s, 1H), 7.65 (d, J = 1.2 Hz, 1H), 7.48 (d, J = 3.6 Hz, 1H), 6.62
(dd, J = 3.6, 1.6 Hz, 1H), 4.03 (s, 3H), 3.97 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 164.8, 164.4, 153.2, 149.4, 148.5, 145.8,
130.0, 120.5, 113.1, 113.0, 53.5, 53.4; HRMS (ESI) m/z: [M +
H]+ Calcd for C12H11N2O5 263.0662, Found 263.0661.
δ, 7.70 (d, J = 8.4 Hz, 2H), 7.63 (d, J = 8.4 Hz, 2H), 3.84 (s, 3H),
3.80 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.0, 160.4, 146.1,
139.6, 132.3, 131.3 (q, J = 32.5 Hz), 128.3, 125.6 (q, J = 3.7 Hz),
123.8 (q, J = 270.6 Hz), 113.8, 52.6, (1C missing); HRMS (ESI)
m/z: [M + Na]+ Calcd for C14H11F3N2O4Na 351.0563, Found
351.0562.
Dimethyl
3-(4-fluorophenyl)-1H-pyrazole-4,5-dicarboxylate.
Compound 3e (63 mg, Y = 76%, Rf = 0.21 (PE:EA = 2:1)) was
isolated as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.58–7.52
(m, 2H), 7.06 (t, J = 8.8 Hz, 2H), 3.82 (s, 3H), 3.74 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 164.1, 163.4 (d, J = 248.6 Hz), 161.0,
145.7, 140.8, 130.1 (d, J = 8.4 Hz), 124.4 (d, J = 3.1 Hz), 115.8 (d,
J = 21.7 Hz), 112.8, 52.4 (2C); HRMS (ESI) m/z: [M + Na]+
Calcd for C13H11FN2O4Na 301.0595, Found 301.0593.
Dimethyl
3-(furan-2-yl)-1H-pyrazole-4,5-dicarboxylate.
Compound 3f (28 mg, Y = 37%, Rf = 0.26 (PE:EA = 2:1)) was
1
Dimethyl 6-(tert-butyl)pyridazine-3,4-dicarboxylate. Compound
2g (32 mg, Y = 42%, Rf = 0.52 (PE:EA = 2:1)) was isolated as a
isolated as a yellow oil. H NMR (400 MHz, CDCl3) δ 7.50 (d, J
= 1.2 Hz, 1H), 7.24 (d, J = 3.2 Hz, 1H), 6.53 (dd, J = 3.2, 1.6 Hz,
1H), 3.93 (s, 3H), 3.93 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
163.2, 161.6, 143.5, 142.9, 142.6, 137.7, 112.6, 112.2, 110.1, 52.6,
52.2; HRMS (ESI) m/z: [M + Na]+ Calcd for C11H10N2O5Na
273.0482, Found 273.0481.
1
yellow oil. H NMR (400 MHz, CDCl3) δ 7.83 (s, 1H), 4.04 (s,
3H), 3.97 (s, 3H), 1.48 (s, 9H); 13C NMR (100 MHz, CDCl3) δ
172.4, 165.3, 164.8, 149.1, 129.2, 122.3, 53.4, 53.3, 37.5, 29.8;
HRMS (ESI) m/z: [M + H]+ Calcd for C12H17N2O4 253.1183,
Found 253.1183.
Dimethyl
3-(tert-Butyl)-1H-pyrazole-4,5-dicarboxylate.
Dimethyl (E)-6-styrylpyridazine-3,4-dicarboxylate. Compound 2h
(61 mg, Y = 68%, Rf = 0.40 (PE:EA = 2:1)) was isolated as a
Compound 3g (56 mg, Y = 78%, Rf = 0.24 (PE:EA = 2:1)) was
1
isolated as a white solid; mp 117−118 °C. H NMR (400 MHz,
yellow solid; mp 149.3−149.6 °C. H NMR (400 MHz, CDCl3) δ
CDCl3) δ 3.90 (s, 3H), 3.88 (s, 3H), 1.40 (s, 9H); 13C NMR (100
MHz, CDCl3) δ 165.6, 161.7, 153.3, 141.5, 112.7, 52.3, 52.1, 32.4,
29.0; HRMS (ESI) m/z: [M + Na]+ Calcd for C11H16N2O4Na
263.1002, Found 263.1001.
1
7.93 (s, 1H), 7.80 (d, J = 16.4 Hz, 1H), 7.62 (d, J = 6.8 Hz, 2H),
7.46–7.37 (m, 4H), 4.05 (s, 3H), 3.99 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 164.9, 164.6, 159.7, 148.8, 138.0, 135.2, 129.8,
129.7, 128.9, 127.7, 123.5, 122.9, 53.5, 53.4; HRMS (ESI) m/z:
[M + H]+ Calcd for C16H15N2O4 299.1026, Found 299.1025.
Diethyl 6-phenylpyridazine-3,4-dicarboxylate. Compound 2i (67
mg, Y = 74%, Rf = 0.45 (PE:EA = 2:1)) was isolated as a yellow
solid; mp 149.3−149.6 °C. 1H NMR (400 MHz, CDCl3) δ 8.18 (s,
1H), 8.17–8.10 (m, 2H), 7.58–7.50 (m, 3H), 4.53 (q, J = 7.2 Hz,
2H), 4.45 (q, J = 7.2 Hz, 2H), 1.45 (t, J = 7.2 Hz, 3H), 1.40 (t, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 164.6, 164.0, 160.5,
150.0, 134.7, 131.1, 129.8, 129.2, 127.4, 122.9, 62.9, 62.7, 14.0,
13.9; HRMS (ESI) m/z: [M + H]+ Calcd for C16H17N2O4
301.1183, Found 301.1181.
(E)-dimethyl 3-styryl-1H-pyrazole-4,5-dicarboxylate. Compound
3h (54 mg, Y = 63%, Rf = 0.20 (PE:EA = 2:1)) was isolated as a
1
white solid; mp 117.5−118.3 °C. H NMR (400 MHz, CDCl3) δ
7.48 (d, J = 7.2 Hz, 2H), 7.40–7.28 (m, 5H), 3.93 (s, 3H), 3.70 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 163.2, 161.7, 145.1, 142.8,
135.6, 134.3, 129.0, 128.7, 127.1, 113.7, 111.5, 52.4, 52.0; HRMS
(ESI) m/z: [M + Na]+ Calcd for C15H14N2O4Na 309.0846, Found
309.0845.
Diethyl 3-phenyl-1H-pyrazole-4,5-dicarboxylate. Compound 3i
(79 mg, Y = 91%, Rf = 0.30 (PE:EA = 2:1)) was isolated as a
1
yellow oil. H NMR (400 MHz, CDCl3) δ 7.60–7.52 (m, 2H),
7.39–7.33 (m, 3H), 4.29 (q, J = 7.2 Hz, 2H), 4.18 (q, J = 7.2 Hz,
2H), 1.26 (t, J = 7.2 Hz, 3H), 1.18 (t, J = 7.2 Hz, 3H); 13C NMR
(100 MHz, CDCl3) δ 163.8, 160.7, 146.1, 141.0, 129.3, 128.5,
128.4, 127.9, 113.3, 61.4, 61.3, 13.9 (2C); HRMS (ESI) m/z: [M
+ Na]+ Calcd for C15H16N2O4Na 311.1002, Found 311.1002.
Characterization Data of Compounds 3a−i.
Dimethyl 3-phenyl-1H-pyrazole-4,5-dicarboxylate. Compound 3a
(72 mg, Y = 92%, Rf = 0.29 (PE:EA = 3:1)) was isolated as a
1
yellow oil. H NMR (400 MHz, CDCl3) δ 7.57–7.51 (m, 2H),
7.37–7.32 (m, 3H), 3.81 (s, 3H), 3.63 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 164.2, 161.1, 146.6, 141.0, 129.6, 128.7, 128.3,
128.0, 113.1, 52.4, 52.4; HRMS (ESI) m/z: [M + Na]+ Calcd for
C13H12N2O4Na 283.0689, Found 283.0688.
ASSOCIATED CONTENT
Supporting Information
Dimethyl
3-(4-methoxyphenyl)-1H-pyrazole-4,5-dicarboxylate.
Compound 3b (74 mg, Y = 85%, Rf = 0.33 (PE:EA = 1:1)) was
The Supporting Information is available free of charge on the
ACS Publications website at DOI:
Copies of 1H and 13C NMR spectra for all new compounds (PDF),
1
isolated as a yellow oil. H NMR (400 MHz, CDCl3) δ 7.50 (d, J
= 7.6 Hz, 2H), 6.90 (d, J = 7.6 Hz, 2H), 3.81 (s, 6H), 3.78 (s, 3H);
13C NMR (100 MHz, CDCl3) δ 164.1, 161.4, 160.7, 146.2, 141.6,
Crystallographic information for 2a and 3g (CIF)
4
ACS Paragon Plus Environment